Arcutis Biotherapeutics, Inc. (ARQT) NASDAQ

17.19

+0.04(+0.23%)

Updated at September 08 03:05PM

Currency In USD

Arcutis Biotherapeutics, Inc.

Address

3027 Townsgate Road

Westlake Village, CA 91361

United States of America

Phone

805 418 5006

Sector

Healthcare

Industry

Biotechnology

Employees

342

First IPO Date

January 31, 2020

Key Executives

NameTitlePayYear Born
Mr. Todd Franklin Watanabe M.A.President, Chief Executive Officer & Director1.23M1968
Dr. Bhaskar Chaudhuri Ph.D.Co-Founder & Independent Director65,0001955
Mr. Masaru Matsuda Esq., J.D.Senior Vice President, General Counsel & Corporate Secretary749,9401971
Dr. Patrick E. Burnett M.D., Ph.D.Executive Vice President & Chief Medical Officer814,7661972
Mr. Rajvir MadanChief Digital & Technology Officer0N/A
Ms. Latha VairavanChief Financial Officer0N/A
Ms. Amanda SheldonHead of Corporate Communications0N/A
Mr. Kent TaylorSenior Vice President of Sales0N/A
Ms. Aleen HosdaghianVice President of Marketing0N/A
Ms. Courtney BartonVice President and Chief Compliance Officer & Privacy Officer01983

Description

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.